Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2023	Mar. 31, 2022
Revenue:
Net revenue	$ 32,436	$ 60,115
Costs and expenses:
Cost of goods sold	16,874	9,370
Research and development	34,154	82,917
Selling, general and administrative	49,153	48,753
Total costs and expenses	100,181	141,040
Loss from operations	(67,745)	(80,925)
Interest expense	(9,712)	(8,969)
Loss on debt extinguishment		(6,222)
Other income (expense), net	1,728	32
Loss before income taxes	(75,729)	(96,084)
Net loss	$ (75,729)	$ (96,084)
Net (loss) income per share:
Basic (In dollar per share)	$ (0.96)	$ (1.24)
Diluted (In dollar per share)	$ (0.96)	$ (1.24)
Weighted-average number of shares used in computing basic and diluted net loss per share:
Basic (In shares)	79,268,853	77,253,699
Diluted (In shares)	79,268,853	77,253,699

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227